MMP9 and neoplasm: Vahid Haghpanah discovers that VPA, as a histone deacetylase inhibitor, reduces the expression of MMP-2 and MMP-9, declines stem cell markers and tumor aggressiveness, and stimulates the anaplastic thyroid cancer cells to redifferentiate.